Sperm bank market seen reaching $6.9 billion by 2033

Persistence Market Research says the global sperm bank market will grow from $5.3 billion in 2026 to $6.9 billion by 2033, driven by infertility, delayed parenthood and wider use of assisted reproductive technologies. North America leads the market now, while Asia Pacific is emerging as a faster-growth region.

Why it matters: - Demand for sperm banking is expanding as more people use assisted reproductive technologies and fertility preservation services. - The market is tied to broader shifts in family planning, including delayed parenthood, donor insemination and fertility treatment for cancer patients. - Growth also signals more investment in reproductive healthcare infrastructure and laboratory capabilities.

What happened: - Persistence Market Research valued the global sperm bank market at US$ 5.3 billion in 2026. - The firm projects the market will reach US$ 6.9 billion by 2033. - The forecast implies a 3.8% compound annual growth rate from 2026 to 2033. - The report was issued from Brenford, London, United Kingdom, on July 23, 2026. - The report is available as a free sample here.

The details: - Donor sperm services are the leading segment because of demand from infertility treatments and family planning among single parents and LGBTQ+ households. - Storage and preservation services are gaining demand as more people bank sperm before medical treatment or delayed family planning. - Fertility clinics are the dominant end-user segment because of rising patient volumes and broader reproductive healthcare offerings. - Hospitals, specialty reproductive centers and research institutions also contribute to demand. - North America leads the market because of advanced healthcare infrastructure, supportive regulation, high awareness and broad use of assisted reproductive technologies. - Europe is another major market, supported by expanding fertility services, awareness and technology adoption. - Asia Pacific is emerging as a growth region as healthcare infrastructure improves, disposable incomes rise, medical tourism expands and fertility preservation awareness grows. - Key market players include California Cryobank, Fairfax Cryobank, Cryos International, Xytex Corporation, Seattle Sperm Bank, New England Cryogenic Center, European Sperm Bank, London Sperm Bank, Indian Spermtech and Androcryos. - The report offers customization here. - The full report can be purchased here.

Between the lines: - The market's growth is being driven by both medical need and changing social norms around reproduction. - Better cryopreservation, genetic screening and donor-matching systems are improving treatment confidence and operational efficiency. - Regulatory differences, donor anonymity rules and high treatment costs remain hurdles, especially across cross-border services and in lower-income markets. - Stigma and limited reimbursement continue to slow adoption in some regions.

What's next: - Fertility providers are expected to keep expanding specialized services and clinic networks. - AI-assisted donor matching, automated lab systems and digital patient platforms could improve efficiency and outcomes. - Partnerships between sperm banks, fertility clinics and research organizations are likely to shape the next phase of market growth. - Rising awareness campaigns around fertility preservation before chemotherapy and other treatments may widen the customer base further.